Asia Research Partners specializes in pharmaceutical, healthcare, and advisory research, bringing clarity to the market forces, trends, and impacts of physician and consumer information technology usage.

Asia Research Partners offers a wide range of market research services to pharmaceutical, biotech, medical device, diagnostics, and global medical research firms. The company offers a wide range of qualitative and quantitative research services, customizing each report according to specific client and project objectives. It is one of the most recognized and fastest-growing research companies in the healthcare industry for its ability to provide its clients with actionable information. The firm’s deliverables are recognized not only for their data collection, analytical and reporting rigor, but also for their presentation-ready formats.

Our intervention covers the entire spectrum of medical and healthcare practitioners.
General Practitioners Radiologists Hospital based Practitioners
Private Practice Specialists Nuclear Medicine doctors Hospital Pharmacists
Nurses Cardiologists Surgeons
Rheumatologist Neonatologist Pulmonologist
Dieticians Oncologists Ophthalmologists
Nephrologist Obstetrician Gynecologist
Psychiatrist Plastic Surgery Internal Medicine
Endocrinologist Physicians Hematologist
Pediatrician Neurologist Urologist
Pediatrician Neurologist Urologist
Interventional Radiologist Interventional Cardiologist Orthopedic Physicians
Oncologist Geriatricians Pathologist
Immunologist Anesthesiologist Dermatologist
Dentists Pharmacists Gastroenterologists
The universes of therapeutics in which we are intervening the most frequently are :
Antibiotherapy Anti-Hypercholesterolemia
Gynecology Diagnostics
Immunology Asthma
Diabetes Cardiology
Endocrinology Physiology
Interventional Cardiology Plastic Surgeon
Radiology Dermatology
Dietetics Pulmonology
Oncology Ophthalmology
Orthopedics Alzheimer
Pediatrics Neurology
Geriatrics Neonatology
Internist Rheumatology
Urology Psychiatry
Gastroenterology Hematology
Interventional radiology Pathology
Nephrology Oncology
Neurology: Multiple
Global Healthcare Market

Having grown at a compound annual growth rate (CAGR) of 7.3% since 2014, the global healthcare market reached nearly $8,452 billion in 2018, and is projected to grow at an 8.9% CAGR to nearly $11,908.9 billion by 2022.

A vital component of the historic period’s growth was the rapid growth in the elderly population, strong growth in emerging markets, and decline in oil prices, as well as reforms in health insurance around the world.¬†Healthcare access issues, labour shortages, manufacturing challenges, and regulatory changes were some of the factors that hindered growth in the past.

Healthcare is segmented into services, pharmaceuticals, medical equipment, biologics, and veterinary healthcare. Healthcare services accounted for 79.4% of the market’s total in 2018. The next segment was pharmaceutical drugs, followed by medical equipment.

The future growth in the healthcare market will be driven by biologics and veterinary medicine, where CAGRs are projected to be 13.6% and 10.9% respectively. The healthcare services market will grow at a CAGR of 9.3%, followed by the pharmaceutical drug market at 6%.

The global healthcare market will have the most opportunities in the healthcare services segment which is projected to make $2,873 billion of global annual revenue by 2022. Women’s healthcare market end-users will also dominate the top opportunities as women’s medical care is projected to drive $1,807.8 billion of global annual sales by 2022. It is estimated that the US health market will grow by $808 billion, making it the region that will benefit most from healthcare sector.

0123456789001234567890                     .0123456789001234567890GDP (in $ trillion in nominal terms)
0123456789001234567890012345678900123456789001234567890Per Capita (in $)
01234567890Real Growth (in %)
01234567890                     .01234567890Health expenditure (in $ trillion or 10% of global GDP)
0123456789001234567890Health expenditure as % of GDP
0123456789001234567890                     .0123456789001234567890Public expenditure in %